Alphinity Australian Share is an Managed Funds investment product that is benchmarked against ASX Index 200 Index and sits inside the Domestic Equity - Large Growth Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Alphinity Australian Share has Assets Under Management of 173.08 M with a management fee of 0.9%, a performance fee of 0.00% and a buy/sell spread fee of 0.4%.
The recent investment performance of the investment product shows that the Alphinity Australian Share has returned 2.31% in the last month. The previous three years have returned 7.86% annualised and 13.38% each year since inception, which is when the Alphinity Australian Share first started.
There are many ways that the risk of an investment product can be measured, and each measurement provides a different insight into the risk present. They can be used on their own or together to perform a risk assessment before investing, but when comparing investments, it is common to compare like for like risk measurements to determine which investment holds the most risk. Since Alphinity Australian Share first started, the Sharpe ratio is NA with an annualised volatility of 13.38%. The maximum drawdown of the investment product in the last 12 months is -3.83% and -51.33% since inception. The maximum drawdown is defined as the high-to-low decline of an investment during a particular time period.
Relative performance is what an asset achieves over a period of time compared to similar investments or its peers. Relative return is a measure of the asset's performance compared to the return to the other investment. The Alphinity Australian Share has a 12-month excess return when compared to the Domestic Equity - Large Growth Index of -1.71% and -0.49% since inception.
Alpha is an investing term used to measure an investment's outperformance relative to a market benchmark or peer investment. Alpha describes the excess return generated when compared to peer investment. Alphinity Australian Share has produced Alpha over the Domestic Equity - Large Growth Index of NA% in the last 12 months and NA% since inception.
For a full list of investment products in the Domestic Equity - Large Growth Index category, you can click here for the Peer Investment Report.
Alphinity Australian Share has a correlation coefficient of 0.98 and a beta of 0.89 when compared to the Domestic Equity - Large Growth Index. Correlation measures how similarly two investments move in relation to one another. This establishes a 'correlation coefficient', which has a value between -1.0 and +1.0. A 100% correlation between two investments means that the correlation coefficient is +1. Beta in investments measures how much the price moves relative to the broader market over a period of time. If the investment moves more than the broader market, it has a beta above 1.0. If it moves less than the broader market, then the beta is less than 1.0. Investments with a high beta tend to carry more risk but have the potential to deliver higher returns.
For a full quantitative report on Alphinity Australian Share and its peer investments, you can click here for the Peer Investment Report.
For a full quantitative report on Alphinity Australian Share compared to the ASX Index 200 Index, you can click here.
To sort and compare the Alphinity Australian Share financial metrics, please refer to the table above.
This investment product is in the process of being independently verified by SMSF Mate. Once we have verified the investment product, you will be able to find more information here.
If you or your self managed super fund would like to invest in the Alphinity Australian Share please contact Level 2, 5 Martin Place, Sydney NSW 2000 via phone +61 133 566 or via email info@challenger.com.au.
If you would like to get in contact with the Alphinity Australian Share manager, please call +61 133 566.
SMSF Mate does not receive commissions or kickbacks from the Alphinity Australian Share. All data and commentary for this fund is provided free of charge for our readers general information.
The Fund outperformed nicely in August with a number of decent winners and almost no losers. The best contributors to returns were from a variety of sectors and, pleasingly, came from our larger active weights: online advertising (carsales.com), industrial property (Goodman Group), pallet pooling (Brambles Industries), medical devices (Cochlear), health insurance (Medibank), gaming (Aristocrat Leisure) and building materials (James Hardie). Not owning medical device company (Resmed) or tech company WiseTech also added to returns. The only noticeable detractor was mineral sands producer Iluka Resources.
The Fund underperformed in July although there were no individually significant entries on either the positive or negative side. The best contributors to returns were energy generator AGL, packaging company Orora and building materials producer James Hardie; biggest detractors were mineral sands/rare earth miner Iluka, pallet pooler Brambles and supermarket operator Woolworths.
The Fund performed in line with the market in June, and across the June quarter. The best contributors were global insurer QBE, pallet pooler Brambles, and advertising platform carsales.com; not owning resource giants South32 or Rio Tinto also added some value.
Offsetting these however were holdings of resource giant BHP and medical device maker Fisher & Paykel Healthcare, while not owning high tech companies Xero and WiseTech detracted from returns.
The Fund lagged the market a little in May, with a holding in respiratory products maker Fisher & Paykel and not holding accounting software provider Xero both detracting from returns. The portfolio benefitted from no exposure to gold miner Newcrest and overweight holdings in Lynas and Viva energy.
The Fund performed essentially in line with the market in April, and there were few companies of note on either side of the ledger; the only meaningful positive contributor was not owning diversified miner Rio Tinto; the only meaningful detractor was owning resource giant BHP.
Despite ongoing macro uncertainty, the portfolio has continued to exhibit better earnings revisions than its benchmark with March quarter updates from Brambles, Medibank Private and Woolworths some of the highlights. Indications of stronger-than-anticipated increases in mobile pricing plans across the telecom sector has also benefitted Telstra.
The mixed news out of China, especially the suggestion that there might be a Government-mandated cap on steel production, has seen weakness across the commodity price complex. The portfolio remains underweight this sector and we trimmed our iron ore exposure somewhat as near term earnings upside has become more limited.
The Fund performed a little better than the market over the March Quarter. The material contributors over the period were quite diverse: gaming company Aristocrat Leisure, health insurer Medibank Private, petrol distributor Viva Energy, packaging company Orora and pallet pool operator Brambles, although these were partially offset by our position in National Australia Bank and not owning gold miner Newcrest.
The Fund outperformed the market nicely in February, helped by strong returns from some of our key positions. The best contributors to overall performance came from health insurer Medibank Private, global insurer QBE, packaging company Orora, pallet mover Brambles Industries, gaming machine maker Aristocrat Leisure and insurance broker Steadfast. The only detractor of note was our position in BHP.
Product Snapshot
Product Overview
Performance Review
Peer Comparison
Product Details